Related Experiment Video
Updated: Oct 10, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas
Abstract:
The neurofibromatosis type 2 (NF2) protein, known as merlin or schwannomin, is a tumor suppressor, and the NF2 gene has been found to be mutated in the majority of schwannomas and meningiomas, including both sporadically occurring and familial NF2 cases. Although the development of these tumors depends on the loss of merlin, the presence of tumors lacking detectable NF2 mutations suggests different mechanisms for inactivating merlin. Recent studies have demonstrated cleavage of merlin by calpain, a calcium-dependent neutral cysteine protease, and marked activation of the calpain system resulting in the degradation of merlin in these tumors. Increased turnover of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.
Insights
Neurofibromatosis type 2 (NF2) protein loss drives schwannomas and meningiomas. Calpain protease activation degrades merlin, a key NF2 protein, contributing to tumor development even without NF2 gene mutations.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a crucial tumor suppressor.
- Mutations in the NF2 gene are frequently observed in schwannomas and meningiomas.
- Tumorigenesis in NF2-related conditions often involves the loss of merlin function.
Purpose of the Study:
- To investigate alternative mechanisms of merlin inactivation in schwannomas and meningiomas.
- To explore the role of calpain protease in merlin degradation and tumor development.
- To understand the calpain-mediated proteolytic pathway in tumorigenesis.
Main Methods:
- Analysis of merlin protein levels in tumors.
- Investigation of calpain activity in tumor samples.
- Assessment of merlin cleavage by calpain in vitro and in vivo.
Main Results:
- Identified tumors lacking detectable NF2 mutations but exhibiting merlin inactivation.
- Demonstrated cleavage and degradation of merlin by calpain, a calcium-dependent protease.
- Observed marked activation of the calpain system in these tumors, leading to increased merlin turnover.
Conclusions:
- Calpain-mediated proteolytic degradation of merlin represents a significant mechanism for tumor development in schwannomas and meningiomas.
- This pathway offers an alternative to NF2 gene mutations for merlin inactivation.
- Targeting the calpain system may present novel therapeutic strategies for NF2-related tumors.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Caspases
Neural Regulation

